Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026
DOI: 10.1016/j.bbcan.2025.189510 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Teresa Rossi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Research, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy. Hauptthemen laut MEDLINE: Mitochondrial Dynamics, Neoplasms, Drug Resistance, Neoplasm, Mitochondria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Mitochondria continuously alternate between fragmented and fused states, a process known as mitochondrial dynamics, which plays a pivotal role in essential cellular functions, including metabolism, apoptosis, reactive oxygen species production, and signal transduction. Disruptions in this dynamic equilibrium, frequently observed in aggressive cancers, can promote malignant transformation and tumor progression. A growing body of evidence indicates that dysregulated mitochondrial dynamics contribute to resistance against both conventional and targeted anticancer therapies. In this review, we explore the regulatory mechanisms governing mitochondrial dynamics, with a focus on the genetic and epigenetic modulation of key drivers such as DRP1, MFN1/2 and OPA1. We also discuss how altered mitochondrial dynamics converge into diverse mechanisms of drug resistance in cancer. Overall, these insights underscore aberrant mitochondrial dynamics as a potential biomarker of therapeutic resistance, and position mitochondrial dynamics-related GTPases, particularly DRP1 and Mitofusins, as exploitable targets for novel treatments in advanced solid and hematologic malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Translational Research, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
- Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
- Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy.
- Scientific Directorate, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
- Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy. Electronic address: amodio@unicz.it.
Förderung
- Ministero della Salute
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Rossi, T., Torcasio, R., Ganino, L., Valentino, I., Boni, C., Gentile, M., Neri, A., Amodio, N., & Pistoni, M. (2026). Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189510
Vancouver
Rossi T, Torcasio R, Ganino L, Valentino I, Boni C, Gentile M, et al. Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2025.189510
BibTeX
@article{Rossi2026,
author = {Rossi, Teresa and Torcasio, Roberta and Ganino, Ludovica and Valentino, Ilenia and Boni, Christian and Gentile, Massimo and Neri, Antonino and Amodio, Nicola and Pistoni, Mariaelena},
title = {Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
doi = {10.1016/j.bbcan.2025.189510}
}
EUVIMED